US Patent Issued to Victor Chang Cardiac Research Institute, National Cerebral and Cardiovascular Center on Sept. 8 for "KLF induced cardiomyogenesis" (Australian Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,226, issued on Sept. 8, was assigned to Victor Chang Cardiac Research Institute (Sydney) and National Cerebral and Cardiovascular Center (Osaka, Japan).

"KLF induced cardiomyogenesis" was invented by Kazu Kikuchi III (Sydney) and Masahito Ogawa (Sydney).

According to the abstract* released by the U.S. Patent & Trademark Office: "The technology relates to a method for inducing cardiomyogenesis comprising administering a therapeutically effective amount of either or both of KLF1 and KLF2b to increase the level of KLF1 and/or KLF2b in the cardiomyocytes thereby inducing cardiomyogenesis."

The patent was filed on July 30, 2020, under Application No. 17/630,263.

*For further informa...